Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Ethynodiol Diacetate
Trade Name
Drug Image
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Progestogenic hormone used in oral contraceptive products.
  • Fetal Risk
    Fetal Risk
  • Possible association with acronym renal or Radial and Limb malformation">vactrel (vertebral, anal, cardiac, tracheal, renal or radial, esophageal and limb) malformations.
  • Norethindrone, norethynodrel, hydroxyprogesterone, medroxyprogesterone, and diethylstilbesterol components of oral contraceptives cause musculinization of female fetus.
  • Cause neonatal hyperbilirubinemia if used before or after conception.
  • Breast Feeding
    Breast Feeding
  • Both estrogens and progestins cross into milk.
  • Associated with suppression of lactation, decreased infant weight gain.
  • Compatible with breast feeding but the lowest effective dose should be chosen and infant weight gain should be monitored.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     10   +   7    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year